Cameron Haffner helps Evansville end five-game skid with 57-40 victory over Missouri StateTownsquare Capital LLC purchased a new stake in shares of Terex Co. ( NYSE:TEX – Free Report ) during the third quarter, HoldingsChannel reports. The fund purchased 4,257 shares of the industrial products company’s stock, valued at approximately $225,000. Other institutional investors and hedge funds have also bought and sold shares of the company. Blue Trust Inc. raised its holdings in Terex by 57.5% during the second quarter. Blue Trust Inc. now owns 512 shares of the industrial products company’s stock valued at $28,000 after acquiring an additional 187 shares during the period. GAMMA Investing LLC grew its position in shares of Terex by 83.3% during the third quarter. GAMMA Investing LLC now owns 737 shares of the industrial products company’s stock valued at $39,000 after purchasing an additional 335 shares in the last quarter. Truvestments Capital LLC purchased a new position in shares of Terex during the third quarter valued at about $41,000. Farther Finance Advisors LLC grew its position in shares of Terex by 74.6% during the third quarter. Farther Finance Advisors LLC now owns 1,180 shares of the industrial products company’s stock valued at $62,000 after purchasing an additional 504 shares in the last quarter. Finally, International Assets Investment Management LLC purchased a new position in shares of Terex during the second quarter valued at about $109,000. 92.88% of the stock is owned by institutional investors. Terex Stock Down 0.4 % Shares of NYSE:TEX opened at $52.94 on Friday. Terex Co. has a 1 year low of $48.11 and a 1 year high of $68.08. The business has a 50 day simple moving average of $53.70 and a two-hundred day simple moving average of $54.94. The firm has a market capitalization of $3.54 billion, a PE ratio of 7.73, a price-to-earnings-growth ratio of 4.49 and a beta of 1.53. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.39 and a quick ratio of 1.16. Terex Dividend Announcement The business also recently declared a quarterly dividend, which will be paid on Thursday, December 19th. Stockholders of record on Friday, November 8th will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 1.28%. The ex-dividend date is Friday, November 8th. Terex’s dividend payout ratio is presently 9.93%. Wall Street Analysts Forecast Growth A number of research analysts have recently weighed in on TEX shares. Citigroup cut their price objective on Terex from $60.00 to $57.00 and set a “neutral” rating for the company in a research report on Monday, September 23rd. Evercore ISI cut their price objective on Terex from $67.00 to $59.00 and set an “outperform” rating for the company in a research report on Monday, August 19th. Robert W. Baird dropped their price target on Terex from $65.00 to $55.00 and set a “neutral” rating for the company in a research report on Thursday, October 31st. JPMorgan Chase & Co. dropped their price target on Terex from $65.00 to $62.00 and set a “neutral” rating for the company in a research report on Monday, October 14th. Finally, The Goldman Sachs Group dropped their price target on Terex from $72.00 to $62.00 and set a “neutral” rating for the company in a research report on Friday, September 20th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $59.56. Get Our Latest Analysis on TEX About Terex ( Free Report ) Terex Corporation manufactures and sells aerial work platforms and materials processing machinery worldwide. It operates in two segments, Materials Processing (MP) and Aerial Work Platforms (AWP). The MP segment designs, manufactures, services, and markets materials processing and specialty equipment, includes crushers, washing systems, screens, trommels, apron feeders, material handlers, pick and carry cranes, rough terrain cranes, tower cranes, wood processing, biomass and recycling equipment, concrete mixer trucks and concrete pavers, conveyors, and related components and replacement parts under the Terex, Powerscreen, Fuchs, EvoQuip, Canica, Cedarapids, CBI, Simplicity, Franna, Terex Ecotec, Finlay, ProAll, ZenRobotics, Terex Washing Systems, Terex MPS, Terex Jaques, Terex Advance, ProStack, Terex Bid-Well, MDS, and Terex Recycling Systems brands. Read More Want to see what other hedge funds are holding TEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Terex Co. ( NYSE:TEX – Free Report ). Receive News & Ratings for Terex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terex and related companies with MarketBeat.com's FREE daily email newsletter .A student leader in the University of Calicut has filed a complaint with R. Bindu, Higher Education Minister, seeking action against P. Raveendran, Vice-Chancellor (V-C), for encouraging “anti-government events” on the campus. In a letter to the Minister, M. Abhinand, general secretary of the Departmental Students’ Union, and a student of M.A. (Comparative Literature), alleged that a seminar had been planned by the Calicut University Staff Organisation, affiliated to the Congress, and the Solidarity of University Employees, affiliated to the Indian Union Muslim League, on Monday (December 9) on ‘Exam modernisation: prospects and challenges’. It will be held at the EMS Seminar Complex from 10.30 a.m. to 12.30 p.m. and Mr. Raveendran is scheduled to open it. This comes against the backdrop of the university’s decision to entrust Maharashtra Knowledge Corporation Ltd., a Maharashtra-based firm, with the implementation of the Kerala Resources for Education Administration and Planning (K-REAP) project under the Kerala State Higher Education Council. The government points out that the project aims to provide “robust, unified, and integrated technology solutions” to address the governance and administrative needs of universities in Kerala. Mr. Abhinand alleged that the event was meant to ‘spread false propaganda’ against the State government’s efforts to modernise higher education. A notice on the event claimed that ‘a private company’ was being assigned the work to update the software used for the conduct of exams in the State’s universities. The notice also claimed that the company had been blacklisted by other State governments for irresponsibly using the private data of students. Those supporting the project, meanwhile, pointed out that the company was a public-sector undertaking. Mr. Abhinand said that Mr. Raveendran, who serves as the ‘in-charge V-C’, inaugurating an event opposing the State government was a serious issue. He further alleged, citing official documents, that permission had been granted for university staff to participate in the seminar. Mr. Abhinand sought action against the V-C for encouraging staff to attend anti-government events. Published - December 08, 2024 07:10 pm IST Copy link Email Facebook Twitter Telegram LinkedIn WhatsApp Reddit
Clay's 15 help Morehead State take down Alice Lloyd 94-63
The SEBI had investigated some suspicious front-running trades related to PNB MetLife India Insurance before this action. New Delhi: Market regulator, the Securities and Exchange Board of India (SEBI) has taken strict action in a front-running case, banning PNB Met Life Insurance Company's equity dealer Sachin Bakul Dagli and eight other entities from the stock market. According to the SEBI, front running was being done by Dagli and eight entities for more than three years and during this period, all of them collectively earned illegal profits of Rs 21.16 crore. The market regulator banned Dagli and the eight entities from the stock market and seized the unlawful gains. The SEBI had investigated some suspicious front-running trades related to PNB MetLife India Insurance before this action. The focus of this investigation was to find out whether the suspicious entities were doing front running in the trade of PNB MetLife India Insurance with the help of other people, including dealers and fund managers. It also sought to find whether SEBI rules have been violated or not. The investigation, which was conducted from January 1, 2021, to July 19, 2024, revealed that most of the trading decisions at PNB MetLife were assigned to Dagli for execution. The investigation found that Dagli, the equity dealer of PNB MetLife, and his brother Tejas Dagli, an equity sales trader at Investec, obtained confidential, non-public information about the upcoming trading decisions of PNB MetLife and Investec. This information was further used to make trading decisions and shared with Sandeep Shambharkar, who executed front-running trades through the accounts of Dhanmata Realty Private Ltd (DRPL), Worthy Distributors Private Ltd (WDPL), and Pragnesh Sanghvi. DRPL and WDPL Directors Arpan Kirtikumar Shah, Kabita Saha, and Jignesh Nikulbhai Dabhi were also involved in carrying out this task. The SEBI said that 6,766 front-running trades have been executed. A profit of Rs 21,15,78,005 was earned from this. Front-running is an illegal practice, entailing a trader or broker receiving confidential information about a large company or institution making a bulk order in a particular stock and creating a position in that particular stock before the big order is executed. In such a situation, when the order is executed by a big company or institution, the trader or broker gets the benefit of the sudden rise in that stock. Stay informed on all the latest news , real-time breaking news updates, and follow all the important headlines in india news and world News on Zee News.— President-elect Donald Trump has formally requested the Supreme Court to delay the implementation of a potential TikTok ban, arguing that his administration needs time to pursue a “political resolution” to the issue. The request was submitted on Friday as TikTok and the Biden administration presented opposing briefs to the court. TikTok called on the justices to strike down a law that could result in the platform’s ban by January 19, 2025, while the Biden administration defended the statute, citing national security concerns. Trump, who filed an amicus brief in the case, maintained a neutral position on the legal dispute. However, he urged the court to extend the deadline for TikTok to divest from its China-based parent company, ByteDance, to allow for a negotiated solution after he assumes office. “President Trump takes no position on the underlying merits of this dispute,” the brief stated. “Instead, he respectfully requests that the Court consider staying the Act’s deadline for divestment of January 19, 2025, while it considers the merits of this case.” The filing marks Trump’s latest intervention in a major national issue before his inauguration. The Republican president-elect has been actively engaging with foreign leaders and business figures at his Mar-a-Lago resort in Florida while assembling his administration. Last week, he met with TikTok CEO Shou Chew to discuss the platform’s future. Trump’s position on TikTok has evolved. During his first term, he attempted to ban the app over national security concerns, but his stance shifted during his 2024 presidential campaign when he joined TikTok to connect with younger voters. His campaign effectively used the platform to share viral, often macho-themed content aimed at engaging male audiences. Despite his opposition to banning the app outright, Trump has reiterated that he still sees potential national security risks with TikTok. TikTok and ByteDance are challenging a law signed by President Joe Biden in April, which mandates TikTok’s divestment from ByteDance or a U.S. ban. The statute was upheld earlier this month by the U.S. Court of Appeals for the District of Columbia Circuit, prompting TikTok to appeal to the Supreme Court. The oral arguments, scheduled for January 10, will address whether the law unlawfully restricts free speech under the First Amendment. TikTok’s legal team argues the statute is based on speculative risks that China could influence TikTok’s U.S. operations through ByteDance, despite no evidence of such interference. “The government concedes that it has no evidence China has ever attempted to do so,” TikTok’s brief stated, adding that the fears are “predicated on future risks.” The Biden administration has defended the law, emphasizing that TikTok’s integration with ByteDance and reliance on proprietary technology developed in China pose inherent risks. Officials argue that Chinese authorities could compel ByteDance to provide data on U.S. users or manipulate content on the platform. However, TikTok maintains that the government’s concerns are unfounded and that a forced divestment would harm its operations and violate free speech protections. With the Supreme Court set to hear arguments in January, the fate of TikTok in the U.S. hangs in the balance. Trump’s plea for a delay signals his intention to address the issue diplomatically after taking office, potentially reshaping the platform’s future in the country. This ongoing legal battle underscores the broader tensions between the U.S. and China over data security and digital sovereignty, with TikTok caught in the crossfire. Source: AP
Nuvo Group Enters into Agreement for Sale of Pregnancy Support Business
Townsquare Capital LLC lowered its stake in shares of Olaplex Holdings, Inc. ( NASDAQ:OLPX – Free Report ) by 17.2% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 50,454 shares of the company’s stock after selling 10,511 shares during the quarter. Townsquare Capital LLC’s holdings in Olaplex were worth $119,000 at the end of the most recent reporting period. Several other hedge funds have also recently modified their holdings of the stock. Pacer Advisors Inc. increased its holdings in Olaplex by 42.0% in the 2nd quarter. Pacer Advisors Inc. now owns 19,686,481 shares of the company’s stock valued at $30,317,000 after acquiring an additional 5,824,889 shares during the last quarter. Vanguard Group Inc. grew its position in shares of Olaplex by 8.4% during the first quarter. Vanguard Group Inc. now owns 11,935,003 shares of the company’s stock valued at $22,915,000 after purchasing an additional 929,693 shares in the last quarter. Renaissance Technologies LLC increased its holdings in shares of Olaplex by 0.6% in the second quarter. Renaissance Technologies LLC now owns 2,501,400 shares of the company’s stock worth $3,852,000 after purchasing an additional 14,200 shares during the last quarter. AQR Capital Management LLC lifted its position in shares of Olaplex by 20.7% in the second quarter. AQR Capital Management LLC now owns 1,073,878 shares of the company’s stock worth $1,654,000 after buying an additional 184,091 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in Olaplex by 10.7% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,066,027 shares of the company’s stock valued at $2,505,000 after buying an additional 102,752 shares during the last quarter. Hedge funds and other institutional investors own 87.37% of the company’s stock. Analyst Upgrades and Downgrades A number of analysts have issued reports on the company. Telsey Advisory Group reaffirmed a “market perform” rating and issued a $3.00 price objective on shares of Olaplex in a research note on Thursday, November 7th. Barclays reduced their price target on shares of Olaplex from $2.00 to $1.50 and set an “equal weight” rating on the stock in a research report on Monday, November 11th. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, Olaplex currently has a consensus rating of “Hold” and a consensus target price of $2.30. Insider Transactions at Olaplex In other news, Director John P. Bilbrey acquired 51,697 shares of Olaplex stock in a transaction that occurred on Monday, November 18th. The shares were bought at an average cost of $1.75 per share, with a total value of $90,469.75. Following the transaction, the director now directly owns 318,418 shares of the company’s stock, valued at $557,231.50. This trade represents a 19.38 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this link . Company insiders own 4.20% of the company’s stock. Olaplex Trading Up 2.4 % Shares of OLPX stock opened at $2.14 on Friday. The company has a market cap of $1.42 billion, a PE ratio of 35.67 and a beta of 2.48. Olaplex Holdings, Inc. has a 1 year low of $1.19 and a 1 year high of $2.98. The stock’s 50 day simple moving average is $2.02 and its two-hundred day simple moving average is $1.95. The company has a debt-to-equity ratio of 0.73, a current ratio of 11.84 and a quick ratio of 10.32. Olaplex ( NASDAQ:OLPX – Get Free Report ) last issued its quarterly earnings results on Thursday, November 7th. The company reported $0.04 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.04. Olaplex had a return on equity of 10.50% and a net margin of 9.78%. The company had revenue of $119.10 million during the quarter, compared to the consensus estimate of $126.51 million. During the same period last year, the company earned $0.05 earnings per share. Olaplex’s revenue was down 3.6% on a year-over-year basis. Research analysts predict that Olaplex Holdings, Inc. will post 0.11 earnings per share for the current year. Olaplex Company Profile ( Free Report ) Olaplex Holdings, Inc develops, manufactures, and sells hair care products in the United States and internationally. The company offers hair care shampoos and conditioners for use in treatment, maintenance, and protection of hair, as well as oil, moisture mask, and nourishing hair serum. It provides hair care products to professional hair salons, retailers, and everyday consumers. Featured Articles Want to see what other hedge funds are holding OLPX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Olaplex Holdings, Inc. ( NASDAQ:OLPX – Free Report ). Receive News & Ratings for Olaplex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olaplex and related companies with MarketBeat.com's FREE daily email newsletter .
When it comes to health, how important is our biological age?Asian Markets Cautious Amid Geopolitical Tensions: Markets Wrap
King and PM honour former US president Jimmy Carter after his death aged 100
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against MGP Ingredients, Inc. (MGPI)
Stock image: Emergency services are at the scene Emergency services are at the scene of a serious collision on the Glenshane Pass. The incident happened on a section of road between Magherafelt and Maghera in Co Londonderry. It’s understood one vehicle is on its side following the incident. In a statement earlier this morning police warned of icy conditions: “Road users are advised to exercise caution when approaching the A6 Glenshane Road due to icy conditions. “Stopping distances increase greatly when weather conditions are poor, so slow down and leave a bigger gap between your vehicle and the vehicle in front.” Stock image: Emergency services are at the scene Watch: NI Travellers arrive home for ChristmasSouth Korea Industrial Output Growth below forecasts (-0.4%) in November: Actual (-0.7%)
NoneGophers’ blowout of Morgan State underscores U’s weak nonconference slate
Pakistan has taken several measures to modernize its armed forces, especially the Pakistan Air Force (PAF), which will soon boast a fleet of the latest 5th generation J-35 stealth fighter jets, acquired from China. Updated: December 29, 2024 1:02 AM IST By : Pakistan is rapidly advancing its military capabilities in its attempt to outgun India in case of another showdown between the two bitter rivals. In recent years, Pakistan has taken several measures to modernize its armed forces, especially the Pakistan Air Force (PAF), which will soon boast a fleet of the latest 5th generation J-35 stealth fighter jets, acquired from China. Reports say that the PAF has inked a deal to acquire 40 J-35 fighter jets, which will be delivered within the next two years. The deal was set in motion in January 2024, when PAF chief Air Chief Marshal Zaheer Ahmed Baber Sidhu had stated that the “foundation for acquiring the J-31 stealth fighter aircraft has already been laid”, and the Chinese-made stealth fighter would join the PAF fleet “in the near future”. Pakistan will have edge over India for over a decade Experts believe Pakistan’s acquisition of the J-35 warplane would give it superiority over the Indian Air Force (IAF) in terms of firepower and aerial supremacy, giving Islamabad a strategic edge over New Delhi over the next decade or more. According to Zia ul Haq Shamsi, a retired PAF officer, the deployment of J-35 fighters can give Pakistan an edge over India for the next 12-14 years. However, some experts consider this period to be limited to around 7-8 years. Let us find out about the capabilities and features of the J-35 stealth fighter jet. Squadron Leader Vijainder K. Thakur (retd), an IAF veteran and military expert, notes that PAF’s acquisition of the J-35 will provide a significant boost to its offensive capabilities, and combined with F-16 and J-10C, the J-35’s land-attack variant would provide Pakistan an edge over India, according to the Eurasian Times. Brendan Mulvaney, the Director at US Air Force’s China Aerospace Studies Institute believes that Pakistan’s move reflects a shift away from Western countries and towards China. However, he asserted that the J-35 effectiveness will also depend on the weapons, sensors and C4ISR (command, control, communications, computers, intelligence, surveillance and reconnaissance) provided by China. India’s push for indigenous 5th gen fighter jets Meanwhile, experts believe that India is at least a decade away from acquiring a 5th-gen stealth combat jet, with its AMCA, unlikely to be inducted in the IAF before 2034. According to the 2024-25 report of the Parliamentary Standing Committee on Defence, deliveries of India’s indigenous Advanced Medium Combat Aircraft (AMCA) fifth-generation fighter jets are expected to start in the next decade. But the Defence Research and Development Organisation (DRDO) is facing several technical and timeline-related challenges which could push the project timeline further back. Currently, only three nations have operational fifth-generation fighters — US, Russia, and China, so realistically, acquiring the Su-57 Felon or the F-35 Lightning II fighter jet from Russia or United States, are the only two options for India to acquire a 5th-gen aircraft. But, so far, the US has not explicitly stated that it would be open to selling the F-35 to India, because India buys a large amount armaments from Russia, including the S-400 air defense system. How Pakistan is building air superiority despite failing economy? Pakistan is facing a severe financial crisis, heavy debt, and its economy is crumbling, yet the country is rapidly expanding its military prowess, spending frantically on acquiring the latest military technology. According to a World Bank report, Pakistan owes $29 billion to China, and $9.16 billion to Saudi Arabia, with Beijing having a 22% share in Islamabad’s total foreign debt. Experts believe that China, the world’s second largest economy, with a $18.7 trillion GDP, is the reason why Pakistan is able to rapidly build its military power, despite its economy being under severe stress. Beijing and Islamabad share deep military ties, and have often referred to each other as “all-weather allies”, and China is helping to modernize all three wings of Pakistan’s armed forces, especially the Pakistan Air Force. India and Pakistan have been engaged in a race to stay ahead of each other in combat aircraft since the 1950s when the two rival nations started building their air power. J-35 features, capabilities The Shenyang J-35 is a 5th generation, twin-engine stealth multirole combat aircraft manufactured by Shenyang Aircraft Corporation (SAC), designed for air superiority and surface strike missions. The J-35 comes in two variants, a land-based variant for the Chinese Army, and a carrier-based variant optimized for catapult-assisted takeoff (CATOBAR) for the Navy. The stealth fighter was unveiled during the Zhuhai Air Show in November this year, and is reportedly a more advanced and “production-ready” iteration of the earlier FC-31 model. Experts say that compared to the the FC-31 or J-31, the J-35 is powered by more powerful WS-19 engines, features a more sophisticated radar system, and improved sensor fusion. The aircraft boasts other advanced features, including improved aerodynamics and stealth capabilities, and a wider range of weapons. Notably, China’s 5th-gen combat plane bears striking similarities with the US-made F-35 Lightning II. For breaking news and live news updates, like us on or follow us on and . Read more on Latest on . TopicsWomen lose 22 minutes of their life with each cigarette they smoke while one shortens a man’s life by 17 minutes, experts have estimated. New predictions by researchers are higher than previous estimates which suggested that each cigarette shortens a smoker's life by 11 minutes. The latest findings, which claim that each cigarette leads to a 20-minute loss of life on average across both genders, are based on more up-to-date figures from long-term studies tracking the health of the population. Researchers from University College London said that the harm caused by smoking is “cumulative” and the sooner a person stops smoking, and the more cigarettes they avoid smoking, the longer they live. The new research, commissioned by the Department for Health and Social Care, suggests that if a 10-cigarettes-a-day smoker quits on 1 January, then by 8 January they could “prevent loss of a full day of life”. By 20 February, their lives could be extended by a whole week. And if their quitting is successful until 5 August, they will likely live for a whole month longer than if they had continued to smoke. The authors said: “Studies suggest that smokers typically lose about the same number of healthy years as they do total years of life. “Thus smoking primarily eats into the relatively healthy middle years rather than shortening the period at the end of life, which is often marked by chronic illness or disability. “So a 60-year-old smoker will typically have the health profile of a 70-year-old non-smoker.” The analysis, which will be published in the Journal of Addiction , states the average of 20 minutes of life expectancy lost for each cigarette “is time that would likely be spent in relatively good health”. It adds: “Stopping smoking at every age is beneficial but the sooner smokers get off this escalator of death, the longer and healthier they can expect their lives to be.” Dr Sarah Jackson, principal research fellow from the UCL Alcohol and Tobacco Research Group, said: “It is vital that people understand just how harmful smoking is and how much quitting can improve their health and life expectancy.” She added: “The sooner a person stops smoking, the longer they live. Quitting at any age substantially improves health and the benefits start almost immediately. “It's never too late to make a positive change for your health and there are a range of effective products and treatments that can help smokers quit for good.” Health officials say smokers can find advice, support and resources with the NHS Quit Smoking app, as well as the online Personal Quit Plan. Public health minister Andrew Gwynne said: “Smoking is an expensive and deadly habit and these findings reveal the shocking reality of this addiction, highlighting how important it is to quit. “The new year offers a perfect chance for smokers to make a new resolution and take that step.” Professor Sanjay Agrawal, special adviser on tobacco at the Royal College of Physicians, added: “Every cigarette smoked costs precious minutes of life, and the cumulative impact is devastating, not only for individuals but also for our healthcare system and economy. “This research is a powerful reminder of the urgent need to address cigarette smoking as the leading preventable cause of death and disease in the UK.”
Copper, aluminium under pressure from weak euro zone PMIJimmy Carter, the 39th president and a Nobel Peace Prize recipient, has died at 100Baker Mayfield throws for 3 TDs, Bucs take over 1st in NFC South with 28-13 win over Raiders
Apple has taken the step of halting the sale of its iPhone 14, iPhone 14 Plus, and iPhone SE (3rd generation) in 29 countries, Northern Ireland. As such, this decision conforms to a recent European Union regulation on the adoption of the USB-C charging standard by all electronic devices, including smartphones before 28th of December, 2024. ET Year-end Special Reads Take That: The gamechanger weapon's India acquired in 2024 10 big-bang policy moves Modi government made in 2024 How governments tried to rein in the social media beast The mandate has the goal of decreasing electronic debris, and of homogenizing charging ports, which Apple contested, claiming it. Even though resistance, Apple moved to USB-C with the debut of the iPhone 15 series as well as with other products - such as iPads and AirPods. Due to this, the previous generations of iPhone models that used the Lightning connector may no longer meet the requirements of the EU regulations and have beenremoved from the market in the EU states, Switzerland, and Northern Ireland. Also Read : Magnus Carlsen Walks Out of World Rapid and Blitz Championships Over Jeans Dispute While Apple has removed these models from its official store, third-party retailers may still sell remaining stocks in some regions, such as Amazon Spain. However, this is expected to be a temporary solution. The discontinuation also coincides with reports of declining iPhone SE sales as anticipation builds for a new model in Spring 2025. Beyond Europe, the directive's impact remains limited for now, with other nations unlikely to implement similar legislation before the iPhone 14 is naturally phased out later this year. Artificial Intelligence(AI) Java Programming with ChatGPT: Learn using Generative AI By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) Basics of Generative AI: Unveiling Tomorrows Innovations By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) Generative AI for Dynamic Java Web Applications with ChatGPT By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) Mastering C++ Fundamentals with Generative AI: A Hands-On By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) Master in Python Language Quickly Using the ChatGPT Open AI By - Metla Sudha Sekhar, IT Specialist and Developer View Program Marketing Performance Marketing for eCommerce Brands By - Zafer Mukeri, Founder- Inara Marketers View Program Office Productivity Zero to Hero in Microsoft Excel: Complete Excel guide 2024 By - Metla Sudha Sekhar, IT Specialist and Developer View Program Finance A2Z Of Money By - elearnmarkets, Financial Education by StockEdge View Program Marketing Modern Marketing Masterclass by Seth Godin By - Seth Godin, Former dot com Business Executive and Best Selling Author View Program Astrology Vastu Shastra Course By - Sachenkumar Rai, Vastu Shashtri View Program Strategy Succession Planning Masterclass By - Nigel Penny, Global Strategy Advisor: NSP Strategy Facilitation Ltd. View Program Data Science SQL for Data Science along with Data Analytics and Data Visualization By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) AI and Analytics based Business Strategy By - Tanusree De, Managing Director- Accenture Technology Lead, Trustworthy AI Center of Excellence: ATCI View Program Web Development A Comprehensive ASP.NET Core MVC 6 Project Guide for 2024 By - Metla Sudha Sekhar, IT Specialist and Developer View Program Marketing Digital Marketing Masterclass by Pam Moore By - Pam Moore, Digital Transformation and Social Media Expert View Program Artificial Intelligence(AI) AI-Powered Python Mastery with Tabnine: Boost Your Coding Skills By - Metla Sudha Sekhar, IT Specialist and Developer View Program Office Productivity Mastering Microsoft Office: Word, Excel, PowerPoint, and 365 By - Metla Sudha Sekhar, IT Specialist and Developer View Program Marketing Digital marketing - Wordpress Website Development By - Shraddha Somani, Digital Marketing Trainer, Consultant, Strategiest and Subject Matter expert View Program Office Productivity Mastering Google Sheets: Unleash the Power of Excel and Advance Analysis By - Metla Sudha Sekhar, IT Specialist and Developer View Program Web Development Mastering Full Stack Development: From Frontend to Backend Excellence By - Metla Sudha Sekhar, IT Specialist and Developer View Program Finance Financial Literacy i.e Lets Crack the Billionaire Code By - CA Rahul Gupta, CA with 10+ years of experience and Accounting Educator View Program Data Science SQL Server Bootcamp 2024: Transform from Beginner to Pro By - Metla Sudha Sekhar, IT Specialist and Developer View Program Also Read : Are engagement rumors true? Taylor Swift has solidified her relationship with Travis Kelce by taking this big initiative, here's all about it FAQs: Can I still buy these iPhones in Europe? Yes, but only through third-party resellers while existing stocks last. Apple has officially removed the iPhone 14 and SE from its European stores. Does this ban apply outside Europe? No, the ban is limited to Europe. However, other countries may observe and implement similar regulations in the future. (You can now subscribe to our Economic Times WhatsApp channel )BNP Paribas Financial Markets raised its holdings in Verona Pharma plc ( NASDAQ:VRNA – Free Report ) by 176.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 60,211 shares of the company’s stock after buying an additional 38,434 shares during the quarter. BNP Paribas Financial Markets owned about 0.08% of Verona Pharma worth $1,732,000 at the end of the most recent quarter. Other hedge funds have also recently made changes to their positions in the company. The Manufacturers Life Insurance Company lifted its stake in Verona Pharma by 77.0% in the third quarter. The Manufacturers Life Insurance Company now owns 105,159 shares of the company’s stock worth $3,025,000 after acquiring an additional 45,741 shares during the period. Loomis Sayles & Co. L P bought a new position in Verona Pharma in the 3rd quarter worth $31,966,000. Jennison Associates LLC lifted its position in shares of Verona Pharma by 54.3% in the 3rd quarter. Jennison Associates LLC now owns 1,740,886 shares of the company’s stock worth $50,085,000 after purchasing an additional 612,854 shares during the period. First Turn Management LLC bought a new stake in shares of Verona Pharma during the 3rd quarter valued at about $16,483,000. Finally, Claro Advisors LLC purchased a new position in shares of Verona Pharma during the third quarter valued at about $209,000. 85.88% of the stock is owned by hedge funds and other institutional investors. Analyst Upgrades and Downgrades Several analysts have commented on the stock. Canaccord Genuity Group raised their price objective on shares of Verona Pharma from $37.00 to $44.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th. Truist Financial raised their target price on Verona Pharma from $38.00 to $44.00 and gave the company a “buy” rating in a research note on Wednesday, October 9th. HC Wainwright upped their price target on Verona Pharma from $36.00 to $42.00 and gave the stock a “buy” rating in a research note on Tuesday, November 5th. Finally, Wells Fargo & Company raised their price objective on Verona Pharma from $50.00 to $64.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. Six research analysts have rated the stock with a buy rating, According to data from MarketBeat, Verona Pharma has an average rating of “Buy” and a consensus target price of $43.83. Verona Pharma Stock Performance Verona Pharma stock opened at $40.50 on Friday. The stock’s 50 day moving average is $35.74 and its 200 day moving average is $26.28. The company has a market capitalization of $3.31 billion, a P/E ratio of -21.09 and a beta of 0.46. Verona Pharma plc has a twelve month low of $11.39 and a twelve month high of $40.76. The company has a quick ratio of 12.88, a current ratio of 13.03 and a debt-to-equity ratio of 0.93. Verona Pharma ( NASDAQ:VRNA – Get Free Report ) last released its earnings results on Monday, November 4th. The company reported ($0.56) EPS for the quarter, missing analysts’ consensus estimates of ($0.44) by ($0.12). The firm had revenue of $5.62 million during the quarter, compared to analysts’ expectations of $2.31 million. During the same quarter in the prior year, the company posted ($0.18) earnings per share. On average, equities research analysts predict that Verona Pharma plc will post -2.11 earnings per share for the current fiscal year. Insider Activity at Verona Pharma In related news, CEO David Zaccardelli sold 110,456 shares of the business’s stock in a transaction that occurred on Monday, October 21st. The shares were sold at an average price of $4.38, for a total value of $483,797.28. Following the completion of the transaction, the chief executive officer now directly owns 14,894,464 shares in the company, valued at $65,237,752.32. The trade was a 0.74 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website . Also, CFO Mark W. Hahn sold 12,936 shares of the stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $5.00, for a total value of $64,680.00. Following the sale, the chief financial officer now owns 14,276,000 shares in the company, valued at approximately $71,380,000. This represents a 0.09 % decrease in their ownership of the stock. The disclosure for this sale can be found here . In the last ninety days, insiders have sold 2,094,432 shares of company stock valued at $9,748,833. 4.80% of the stock is owned by insiders. Verona Pharma Profile ( Free Report ) Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. Recommended Stories Want to see what other hedge funds are holding VRNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Verona Pharma plc ( NASDAQ:VRNA – Free Report ). Receive News & Ratings for Verona Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verona Pharma and related companies with MarketBeat.com's FREE daily email newsletter .
1 Monster Stock That Turned $10,000 Into $333 MillionNobel recipient Geoffrey Hinton wishes he thought of AI safety sooner